Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.96 -0.24 (-7.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ernexa Therapeutics (ERNA) Depreciation and Depletion (2018 - 2021)

Updated

Ernexa Therapeutics' Depreciation and Depletion came in at $100,000 for FY2025, unchanged from $100,000 in FY2024.

Analysis

Ernexa Therapeutics (ERNA) Depreciation and Depletion (2018 - 2021) Analysis & Trends

Going back to FY2011, Ernexa Therapeutics' Depreciation and Depletion data covers 15 years.

  • Depreciation and Depletion carries a five-year compound annual growth rate of 0.4% (FY2020 to FY2025).
  • The five-year range for annual Depreciation and Depletion is $100,000 (FY2023) to $200,000 (FY2022).
  • Per Business Quant, earlier years put Depreciation and Depletion at $100,000 in FY2024 (unchanged), $100,000 in FY2023 (-50.0%), $200,000 in FY2022 (+70.9%) and $117,000 in FY2021 (+19.4%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Depletion (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Ernexa Therapeutics 3.74 Mn 3.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 25,163.00
Mar 31, 2020 22,999.00
Jun 30, 2018 21,000.00
Mar 31, 2018 7,000.00
API Access

Ernexa Therapeutics Depreciation and Depletion API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-depletion&ticker=ERNA&period=max&api_key=YOUR_API_KEY